Zohara Sternberg

Summary

Affiliation: University at Buffalo
Country: USA

Publications

  1. ncbi The prevalence of the classical and non-classical cardiovascular risk factors in multiple sclerosis patients
    Zohara Sternberg
    Buffalo Medical Center, Buffalo, NY 14203, USA
    CNS Neurol Disord Drug Targets 12:104-11. 2013
  2. ncbi Autonomic dysfunction: a unifying multiple sclerosis theory, linking chronic cerebrospinal venous insufficiency, vitamin D(3), and Epstein-Barr virus
    Zohara Sternberg
    Department of Neurology, Baird MS Center, Jacobs Neurological Institute, 100 High St Buffalo, NY 14203, USA
    Autoimmun Rev 12:250-9. 2012
  3. ncbi Lp-PLA2: inflammatory biomarker of vascular risk in multiple sclerosis
    Zohara Sternberg
    Department of Neurology, Baird MS Center, Jacobs Neurological Institute, Buffalo, NY 14203, USA
    J Clin Immunol 32:497-504. 2012
  4. ncbi Sympathetic nervous system dysfunction in multiple sclerosis, linking neurodegeneration to a reduced response to therapy
    Zohara Sternberg
    Department of Neurology, Baird MS Center, Jacobs Neurological Institute, 100 High St Buffalo, NY 14203, USA
    Curr Pharm Des 18:1635-44. 2012
  5. ncbi Acamprosate modulates experimental autoimmune encephalomyelitis
    Z Sternberg
    Department of Neurology, Baird MS Center, Jacobs Neurological Institute, 100 High Street, Buffalo, NY 14203, USA
    Inflammopharmacology 20:39-48. 2012
  6. ncbi AGE-RAGE in multiple sclerosis brain
    Zohara Sternberg
    Department of Neurology, Jacobs Neurological Institute, Buffalo, New York 14223, USA
    Immunol Invest 40:197-205. 2011
  7. ncbi Diagnostic potential of plasma carboxymethyllysine and carboxyethyllysine in multiple sclerosis
    Zohara Sternberg
    Department of Neurology, Baird MS Center, Jacobs Neurological Institute, 100 High St, Buffalo, NY 14203, USA
    J Neuroinflammation 7:72. 2010
  8. ncbi Plasma pentosidine: a potential biomarker in the management of multiple sclerosis
    Zohara Sternberg
    Department of Neurology, Baird MS Center, Jacobs Neurological Institute, Buffalo, NY, USA
    Mult Scler 17:157-63. 2011
  9. ncbi Immunomodulatory responses of peripheral blood mononuclear cells from multiple sclerosis patients upon in vitro incubation with the flavonoid luteolin: additive effects of IFN-beta
    Zohara Sternberg
    Department of Neurology, Baird MS Center, Jacobs Neurological Institute, Buffalo, NY, USA
    J Neuroinflammation 6:28. 2009
  10. ncbi Quercetin and interferon-beta modulate immune response(s) in peripheral blood mononuclear cells isolated from multiple sclerosis patients
    Zohara Sternberg
    Department of Neurology, Baird MS Center, Jacobs Neurological Institute, Buffalo, NY 14223, United States
    J Neuroimmunol 205:142-7. 2008

Detail Information

Publications12

  1. ncbi The prevalence of the classical and non-classical cardiovascular risk factors in multiple sclerosis patients
    Zohara Sternberg
    Buffalo Medical Center, Buffalo, NY 14203, USA
    CNS Neurol Disord Drug Targets 12:104-11. 2013
    ..001. Conclusion: The MS pathophysiology may be among factors for the lower CV risk factors in MS patients. Future studies should examine whether the chronic use of many pharmacological agents influence CV risk factors in MS patients...
  2. ncbi Autonomic dysfunction: a unifying multiple sclerosis theory, linking chronic cerebrospinal venous insufficiency, vitamin D(3), and Epstein-Barr virus
    Zohara Sternberg
    Department of Neurology, Baird MS Center, Jacobs Neurological Institute, 100 High St Buffalo, NY 14203, USA
    Autoimmun Rev 12:250-9. 2012
    ..Future studies should investigate CCSVI in relation to cardiovascular autonomic function...
  3. ncbi Lp-PLA2: inflammatory biomarker of vascular risk in multiple sclerosis
    Zohara Sternberg
    Department of Neurology, Baird MS Center, Jacobs Neurological Institute, Buffalo, NY 14203, USA
    J Clin Immunol 32:497-504. 2012
    ..8 ± 5 nmol/min/ml) and compared to HCs. Lp-PLA2 plasma activity was associated with measures of MS clinical disability. However, this association was attenuated after adjustment for the components of lipid profiles...
  4. ncbi Sympathetic nervous system dysfunction in multiple sclerosis, linking neurodegeneration to a reduced response to therapy
    Zohara Sternberg
    Department of Neurology, Baird MS Center, Jacobs Neurological Institute, 100 High St Buffalo, NY 14203, USA
    Curr Pharm Des 18:1635-44. 2012
    ..This algorithm, corrected for age and gender, would have the potential to identify MS patients who have a reduced response to immunomodulatory therapies...
  5. ncbi Acamprosate modulates experimental autoimmune encephalomyelitis
    Z Sternberg
    Department of Neurology, Baird MS Center, Jacobs Neurological Institute, 100 High Street, Buffalo, NY 14203, USA
    Inflammopharmacology 20:39-48. 2012
    ..This pilot study aimed to determine the efficacy of acamprosate (N-acetyl homotaurine) in reducing the pathological features of experimental autoimmune encephalomyelitis (EAE) which is an animal model for multiple sclerosis (MS)...
  6. ncbi AGE-RAGE in multiple sclerosis brain
    Zohara Sternberg
    Department of Neurology, Jacobs Neurological Institute, Buffalo, New York 14223, USA
    Immunol Invest 40:197-205. 2011
    ..Results showed increased AGE and RAGE immunostaining in the hippocampi of MS patients, similar to AD patients...
  7. ncbi Diagnostic potential of plasma carboxymethyllysine and carboxyethyllysine in multiple sclerosis
    Zohara Sternberg
    Department of Neurology, Baird MS Center, Jacobs Neurological Institute, 100 High St, Buffalo, NY 14203, USA
    J Neuroinflammation 7:72. 2010
    ....
  8. ncbi Plasma pentosidine: a potential biomarker in the management of multiple sclerosis
    Zohara Sternberg
    Department of Neurology, Baird MS Center, Jacobs Neurological Institute, Buffalo, NY, USA
    Mult Scler 17:157-63. 2011
    ..The chronic inflammation associated with multiple sclerosis (MS) may lead to the upregulation of pentosidine...
  9. ncbi Immunomodulatory responses of peripheral blood mononuclear cells from multiple sclerosis patients upon in vitro incubation with the flavonoid luteolin: additive effects of IFN-beta
    Zohara Sternberg
    Department of Neurology, Baird MS Center, Jacobs Neurological Institute, Buffalo, NY, USA
    J Neuroinflammation 6:28. 2009
    ..Luteolin reduced the MMP-9/TIMP-1 ratio via lowering MMP-9 production. In the majority of cases, luteolin, when combined with IFN-beta, had additive effects in modulating cell proliferation, IL-1beta, TNF-alpha, MMP-9 and TIMP-1...
  10. ncbi Quercetin and interferon-beta modulate immune response(s) in peripheral blood mononuclear cells isolated from multiple sclerosis patients
    Zohara Sternberg
    Department of Neurology, Baird MS Center, Jacobs Neurological Institute, Buffalo, NY 14223, United States
    J Neuroimmunol 205:142-7. 2008
    ..Quercetin, when combined with IFN-beta, had additive effects in modulating TNF-alpha and MMP-9. These immunomodulatory responses to quercetin were similar between MS patients and healthy control (HC) subjects...
  11. ncbi Soluble receptor for advanced glycation end products in multiple sclerosis: a potential marker of disease severity
    Z Sternberg
    Department of Neurology, Baird MS Center, Jacobs Neurological Institute, Buffalo, NY 14203, USA
    Mult Scler 14:759-63. 2008
    ....
  12. ncbi Faith-placed cardiovascular health promotion: a framework for contextual and organizational factors underlying program success
    Zohara Sternberg
    The Jacobs Neurological Institute, Buffalo General Hospital, 100 High Street, Buffalo, NY 14203, USA
    Health Educ Res 22:619-29. 2007
    ..Each cluster consists of several factors, whose relative weights cannot be ascertained from the present state of the literature. These clusters of factors can be interrelated through a simple framework that is useful in program design...